New Zealand markets closed

Gritstone bio, Inc. (GRTS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9627+0.0927 (+10.66%)
At close: 04:00PM EDT
0.9450 -0.02 (-1.84%)
After hours: 07:53PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-138,490
-138,490
-119,687
-75,082
-105,314
Depreciation & amortisation
7,591
7,591
6,560
6,347
6,644
Stock-based compensation
11,618
11,618
12,557
10,552
7,110
Change in working capital
-17,135
-17,135
-24,527
-1,364
-4,931
Accounts payable
-1,968
-1,968
1,879
-419
826
Other working capital
-126,220
-126,220
-121,818
-56,141
-92,617
Other non-cash items
15,475
15,475
9,523
8,052
7,511
Net cash provided by operating activities
-121,648
-121,648
-115,946
-50,678
-89,102
Cash flows from investing activities
Investments in property, plant and equipment
-4,572
-4,572
-5,872
-5,463
-3,515
Purchases of investments
-26,295
-26,295
-141,908
-199,905
-8,809
Sales/maturities of investments
133,208
133,208
134,816
87,053
78,273
Other investing activities
-
-
-
-238
-
Net cash used for investing activities
102,341
102,341
-12,964
-118,553
65,949
Cash flows from financing activities
Debt repayment
-240
-240
-228
-56
0
Common stock issued
8,092
8,092
64,737
112,888
134,796
Other financing activities
-3,494
-3,494
-1,310
-8,394
-104
Net cash used provided by (used for) financing activities
25,117
25,117
83,098
108,760
135,801
Net change in cash
5,810
5,810
-45,812
-60,471
112,648
Cash at beginning of period
64,765
64,765
110,577
171,048
58,400
Cash at end of period
70,575
70,575
64,765
110,577
171,048
Free cash flow
Operating cash flow
-121,648
-121,648
-115,946
-50,678
-89,102
Capital expenditure
-4,572
-4,572
-5,872
-5,463
-3,515
Free cash flow
-126,220
-126,220
-121,818
-56,141
-92,617